Current Management of Infantile Hemangiomas

Sheilagh M. Maguiness, Ilona J. Frieden

Research output: Contribution to journalReview article

74 Citations (Scopus)

Abstract

During the past several years, there have been new advancements in the management of infantile hemangiomas (IHs). In many patients, no treatment is ever necessary-because IHs are well known for their natural history of spontaneous involution. However, a significant minority of hemangiomas do require treatment. Moreover, they are very heterogeneous, making the decision of when, how, and why to intervene quite variable. The least common but most important rationale for intervention is the presence of a life- or function-threatening complication, where prompt therapeutic intervention is a necessity. A much more common scenario is ulceration, where appropriate management is needed to expedite healing and control pain. Increasingly, the life-altering aspects of hemangioma are being recognized as a rationale for treatment because permanent scarring and disfigurement can result even if involution is complete. Treatments for IHs currently include topical, intralesional, and systemic therapies. Laser and surgical modalities are also sometimes used depending on the clinical scenario. In the absence of rigorous evidence-based studies, clinicians must carefully weigh the risks and benefits of medical or surgical treatments versus observation alone in tailoring management to the specific clinical situation at hand.

Original languageEnglish (US)
Pages (from-to)106-114
Number of pages9
JournalSeminars in Cutaneous Medicine and Surgery
Volume29
Issue number2
DOIs
StatePublished - Jun 1 2010

Fingerprint

Hemangioma
Therapeutics
Natural History
Cicatrix
Decision Making
Lasers
Hand
Observation
Pain

Cite this

Current Management of Infantile Hemangiomas. / Maguiness, Sheilagh M.; Frieden, Ilona J.

In: Seminars in Cutaneous Medicine and Surgery, Vol. 29, No. 2, 01.06.2010, p. 106-114.

Research output: Contribution to journalReview article

@article{a36fe518da284a669c41cf6f1382b754,
title = "Current Management of Infantile Hemangiomas",
abstract = "During the past several years, there have been new advancements in the management of infantile hemangiomas (IHs). In many patients, no treatment is ever necessary-because IHs are well known for their natural history of spontaneous involution. However, a significant minority of hemangiomas do require treatment. Moreover, they are very heterogeneous, making the decision of when, how, and why to intervene quite variable. The least common but most important rationale for intervention is the presence of a life- or function-threatening complication, where prompt therapeutic intervention is a necessity. A much more common scenario is ulceration, where appropriate management is needed to expedite healing and control pain. Increasingly, the life-altering aspects of hemangioma are being recognized as a rationale for treatment because permanent scarring and disfigurement can result even if involution is complete. Treatments for IHs currently include topical, intralesional, and systemic therapies. Laser and surgical modalities are also sometimes used depending on the clinical scenario. In the absence of rigorous evidence-based studies, clinicians must carefully weigh the risks and benefits of medical or surgical treatments versus observation alone in tailoring management to the specific clinical situation at hand.",
author = "Maguiness, {Sheilagh M.} and Frieden, {Ilona J.}",
year = "2010",
month = "6",
day = "1",
doi = "10.1016/j.sder.2010.03.009",
language = "English (US)",
volume = "29",
pages = "106--114",
journal = "Seminars in Cutaneous Medicine and Surgery",
issn = "1085-5629",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Current Management of Infantile Hemangiomas

AU - Maguiness, Sheilagh M.

AU - Frieden, Ilona J.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - During the past several years, there have been new advancements in the management of infantile hemangiomas (IHs). In many patients, no treatment is ever necessary-because IHs are well known for their natural history of spontaneous involution. However, a significant minority of hemangiomas do require treatment. Moreover, they are very heterogeneous, making the decision of when, how, and why to intervene quite variable. The least common but most important rationale for intervention is the presence of a life- or function-threatening complication, where prompt therapeutic intervention is a necessity. A much more common scenario is ulceration, where appropriate management is needed to expedite healing and control pain. Increasingly, the life-altering aspects of hemangioma are being recognized as a rationale for treatment because permanent scarring and disfigurement can result even if involution is complete. Treatments for IHs currently include topical, intralesional, and systemic therapies. Laser and surgical modalities are also sometimes used depending on the clinical scenario. In the absence of rigorous evidence-based studies, clinicians must carefully weigh the risks and benefits of medical or surgical treatments versus observation alone in tailoring management to the specific clinical situation at hand.

AB - During the past several years, there have been new advancements in the management of infantile hemangiomas (IHs). In many patients, no treatment is ever necessary-because IHs are well known for their natural history of spontaneous involution. However, a significant minority of hemangiomas do require treatment. Moreover, they are very heterogeneous, making the decision of when, how, and why to intervene quite variable. The least common but most important rationale for intervention is the presence of a life- or function-threatening complication, where prompt therapeutic intervention is a necessity. A much more common scenario is ulceration, where appropriate management is needed to expedite healing and control pain. Increasingly, the life-altering aspects of hemangioma are being recognized as a rationale for treatment because permanent scarring and disfigurement can result even if involution is complete. Treatments for IHs currently include topical, intralesional, and systemic therapies. Laser and surgical modalities are also sometimes used depending on the clinical scenario. In the absence of rigorous evidence-based studies, clinicians must carefully weigh the risks and benefits of medical or surgical treatments versus observation alone in tailoring management to the specific clinical situation at hand.

UR - http://www.scopus.com/inward/record.url?scp=77953315481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953315481&partnerID=8YFLogxK

U2 - 10.1016/j.sder.2010.03.009

DO - 10.1016/j.sder.2010.03.009

M3 - Review article

VL - 29

SP - 106

EP - 114

JO - Seminars in Cutaneous Medicine and Surgery

JF - Seminars in Cutaneous Medicine and Surgery

SN - 1085-5629

IS - 2

ER -